CMML

 circulating IMC (%)
# cytopenia
AA_CHANGE
AA_CHANGE.1
AA_CHANGE.10
AA_CHANGE.11
AA_CHANGE.12
AA_CHANGE.13
AA_CHANGE.14
AA_CHANGE.15
AA_CHANGE.16
AA_CHANGE.17
AA_CHANGE.18
AA_CHANGE.19
AA_CHANGE.2
AA_CHANGE.20
AA_CHANGE.21
AA_CHANGE.22
AA_CHANGE.23
AA_CHANGE.24
AA_CHANGE.25
AA_CHANGE.26
AA_CHANGE.27
AA_CHANGE.28
AA_CHANGE.29
AA_CHANGE.3
AA_CHANGE.30
AA_CHANGE.31
AA_CHANGE.32
AA_CHANGE.33
AA_CHANGE.34
AA_CHANGE.35
AA_CHANGE.36
AA_CHANGE.37
AA_CHANGE.38
AA_CHANGE.39
AA_CHANGE.4
AA_CHANGE.40
AA_CHANGE.41
AA_CHANGE.42
AA_CHANGE.43
AA_CHANGE.44
AA_CHANGE.5
AA_CHANGE.6
AA_CHANGE.7
AA_CHANGE.8
AA_CHANGE.9
AMC
AML
ANC  at Dx
ASXL1
Abs Eos 
Abs Neut
Abs bas 
Abs lym  
Abs mono
Age at Dx
Allo BMT
BCOR
BM ring sidroblasts
BRAF
Bas %
Blast% BMBx
CBL
CDKN2A
CDNA_CHANGE
CDNA_CHANGE.1
CDNA_CHANGE.10
CDNA_CHANGE.11
CDNA_CHANGE.12
CDNA_CHANGE.13
CDNA_CHANGE.14
CDNA_CHANGE.15
CDNA_CHANGE.16
CDNA_CHANGE.17
CDNA_CHANGE.18
CDNA_CHANGE.19
CDNA_CHANGE.2
CDNA_CHANGE.20
CDNA_CHANGE.21
CDNA_CHANGE.22
CDNA_CHANGE.23
CDNA_CHANGE.24
CDNA_CHANGE.25
CDNA_CHANGE.26
CDNA_CHANGE.27
CDNA_CHANGE.28
CDNA_CHANGE.29
CDNA_CHANGE.3
CDNA_CHANGE.30
CDNA_CHANGE.31
CDNA_CHANGE.32
CDNA_CHANGE.33
CDNA_CHANGE.34
CDNA_CHANGE.35
CDNA_CHANGE.36
CDNA_CHANGE.37
CDNA_CHANGE.38
CDNA_CHANGE.39
CDNA_CHANGE.4
CDNA_CHANGE.40
CDNA_CHANGE.41
CDNA_CHANGE.42
CDNA_CHANGE.43
CDNA_CHANGE.44
CDNA_CHANGE.5
CDNA_CHANGE.6
CDNA_CHANGE.7
CDNA_CHANGE.8
CDNA_CHANGE.9
CEBPA
CHR
CHR.1
CHR.10
CHR.11
CHR.12
CHR.13
CHR.14
CHR.15
CHR.16
CHR.17
CHR.18
CHR.19
CHR.2
CHR.20
CHR.21
CHR.22
CHR.23
CHR.24
CHR.25
CHR.26
CHR.27
CHR.28
CHR.29
CHR.3
CHR.30
CHR.31
CHR.32
CHR.33
CHR.34
CHR.35
CHR.36
CHR.37
CHR.38
CHR.39
CHR.4
CHR.40
CHR.41
CHR.42
CHR.43
CHR.44
CHR.5
CHR.6
CHR.7
CHR.8
CHR.9
CONSEQUENCE
CONSEQUENCE.1
CONSEQUENCE.10
CONSEQUENCE.11
CONSEQUENCE.12
CONSEQUENCE.13
CONSEQUENCE.14
CONSEQUENCE.15
CONSEQUENCE.16
CONSEQUENCE.17
CONSEQUENCE.18
CONSEQUENCE.19
CONSEQUENCE.2
CONSEQUENCE.20
CONSEQUENCE.21
CONSEQUENCE.22
CONSEQUENCE.23
CONSEQUENCE.24
CONSEQUENCE.25
CONSEQUENCE.26
CONSEQUENCE.27
CONSEQUENCE.28
CONSEQUENCE.29
CONSEQUENCE.3
CONSEQUENCE.30
CONSEQUENCE.31
CONSEQUENCE.32
CONSEQUENCE.33
CONSEQUENCE.34
CONSEQUENCE.35
CONSEQUENCE.36
CONSEQUENCE.37
CONSEQUENCE.38
CONSEQUENCE.39
CONSEQUENCE.4
CONSEQUENCE.40
CONSEQUENCE.41
CONSEQUENCE.42
CONSEQUENCE.43
CONSEQUENCE.44
CONSEQUENCE.5
CONSEQUENCE.6
CONSEQUENCE.7
CONSEQUENCE.8
CONSEQUENCE.9
CUX1
Cellularity %
Cellularitycat
DNMT3A
Date of AML
Date of BMT
Date of Diagnosis/Sampling
Double of singe mutation
ECOG PS
ETV6
EZH2
Eos %
FAB Category
FLT3-ITD
FLT3-TKD
Ferritin >1000
GATA2
GENDER
HgB at Dx
IDH1
IDH2
Institution
JAK2
KDM5A
KDM6A
KIT
KRAS
Karyotype at Diagnosis
LDH  at Dx
LUC7L2
Lym %
Lymphoctes  at Dx
MED12
MLL
Mono %
Monocytes at Dx
NF1
NPM1
NRAS
Neut %
PHF6
PLT TX 
PRPF40
PRPF40B
PRPF8
PTEN
PTPN11
PatientID
Position end
Position end.1
Position end.10
Position end.11
Position end.12
Position end.13
Position end.14
Position end.15
Position end.16
Position end.17
Position end.18
Position end.19
Position end.2
Position end.20
Position end.21
Position end.22
Position end.23
Position end.24
Position end.25
Position end.26
Position end.27
Position end.28
Position end.29
Position end.3
Position end.30
Position end.31
Position end.32
Position end.33
Position end.34
Position end.35
Position end.36
Position end.37
Position end.38
Position end.39
Position end.4
Position end.40
Position end.41
Position end.42
Position end.43
Position end.44
Position end.5
Position end.6
Position end.7
Position end.8
Position end.9
Position start
Position start.1
Position start.10
Position start.11
Position start.12
Position start.13
Position start.14
Position start.15
Position start.16
Position start.17
Position start.18
Position start.19
Position start.2
Position start.20
Position start.21
Position start.22
Position start.23
Position start.24
Position start.25
Position start.26
Position start.27
Position start.28
Position start.29
Position start.3
Position start.30
Position start.31
Position start.32
Position start.33
Position start.34
Position start.35
Position start.36
Position start.37
Position start.38
Position start.39
Position start.4
Position start.40
Position start.41
Position start.42
Position start.43
Position start.44
Position start.5
Position start.6
Position start.7
Position start.8
Position start.9
RACE
RAD21
RUNX1
Result
Result.1
Result.10
Result.11
Result.12
Result.13
Result.14
Result.15
Result.16
Result.17
Result.18
Result.19
Result.2
Result.20
Result.21
Result.22
Result.23
Result.24
Result.25
Result.26
Result.27
Result.28
Result.29
Result.3
Result.30
Result.31
Result.32
Result.33
Result.34
Result.35
Result.36
Result.37
Result.38
Result.39
Result.4
Result.40
Result.41
Result.42
Result.43
Result.44
Result.5
Result.6
Result.7
Result.8
Result.9
Reticulin Fibrosis
SF1
SF3B1
SMC3
SRSF2
STAG2
Splenomegaly
TET2
TP53
Tx RBC
U2AF1
U2AF2
VAF
VAF.1
VAF.10
VAF.11
VAF.12
VAF.13
VAF.14
VAF.15
VAF.16
VAF.17
VAF.18
VAF.19
VAF.2
VAF.20
VAF.21
VAF.22
VAF.23
VAF.24
VAF.25
VAF.26
VAF.27
VAF.28
VAF.29
VAF.3
VAF.30
VAF.31
VAF.32
VAF.33
VAF.34
VAF.35
VAF.36
VAF.37
VAF.38
VAF.39
VAF.4
VAF.40
VAF.41
VAF.42
VAF.43
VAF.44
VAF.5
VAF.6
VAF.7
VAF.8
VAF.9
Vital Status
WBC  at Dx
WHO Category
WT1
ZRSR2
circulating blasts (%)
dataset_id
date of last contact/death
karyo CPSS
karyo by IPSS
platelets  at Dx
